Albert L. Reese Jr. - 26 Apr 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Issuer symbol
LEXX
Transactions as of
26 Apr 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 16:52:23 UTC
Previous filing
25 Jul 2023
Next filing
30 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 10,917 26 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +5,000 +33% $0.000000 20,000 26 Apr 2024 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 3,400 26 Apr 2024 Common Shares 3,400 $3.00 Direct F1
holding LEXX Stock Options 6,800 26 Apr 2024 Common Shares 3,400 $3.39 Direct
holding LEXX Stock Options 10,000 26 Apr 2024 Common Shares 3,200 $1.96 Direct
holding LEXX Stock Options 15,000 26 Apr 2024 Common Shares 5,000 $0.8700 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Repriced from $4.80 pursuant to shareholder approval received on May 9, 2023